Citation Impact
Citing Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
2005
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.
1997
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
2001 Standout
Schizophrenia risk from complex variation of complement component 4
2016 StandoutNature
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Effects of Short-Chain Fatty Acids on the Inflamed Colonic Mucosa
1997
Oral butyrate for mildly to moderately active Crohn's disease
2005
Cancer in inflammatory bowel disease
2008
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
2008
Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
2003
Exposing the Weaknesses: A Systematic Review of Azathioprine Efficacy in Ulcerative Colitis
2007
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
2011
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohnʼs disease of the colon
2008
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Review article: the role of butyrate on colonic function
2007 Standout
Do preoperative factors predict subsequent diagnosis of Crohn’s disease after ileal pouch‐anal anastomosis for ulcerative or indeterminate colitis?
2009
Family history as a risk factor for colorectal cancer in inflammatory bowel disease
2001
Ulcerative Colitis
2011 Standout
In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis
2000
Factors associated with disease activity of pouchitis after surgery for ulcerative colitis
2004
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Long-term treatment of rectovaginal fistulas in Crohn’s disease: Response to infliximab in the ACCENT II Study
2004
Bacterial Colonization and the Development of Intestinal Defences
2004
Genetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis
2016
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice
2004
Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis
2002
Cancer Metastasis: Building a Framework
2006 Standout
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
2010
Guidelines for the management of inflammatory bowel disease in adults
2011
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
2005
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
2010
Family History and Serology Predict Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis
2007
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
A Proposed Classification of Ileal Pouch Disorders and Associated Complications After Restorative Proctocolectomy
2008
Male Issues of the Ileal Pouch
2014
Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients
2016
Diagnosis and management of pouchitis1 1Abbreviations used in this paper: EIM, extraintestinal manifestations; FAP, familial adenomatous polyposis; IL, interleukin; IPAA, ileal pouch anal anastomosis; pANCA, serum antineutrophil cytoplasmic antibody-perinuclear staining pattern; PAS, Pouchitis Activity Score; PDAI, Pouchitis Disease Activity Index; PSC, primary sclerosing cholangitis; QOL, quality of life; SCFA, small chain fatty acids.
2003
Psoriasis
2021 Standout
Ulcerative colitis
2002
Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: A randomized trial
2015
Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
2008
A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon
2007
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
2009 StandoutNature
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study
2007
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
2003
Inflammatory Bowel Disease
2009 Standout
Development of Colonic Adenocarcinomas in a Mouse Model of Ulcerative Colitis
1998
Has disease outcome in Crohn's disease changed during the last four decades?
2004
Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine
2008
Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001
2004
Metagenomic biomarker discovery and explanation
2011 Standout
Revolution and evolution: 30 years of ileoanal pouch surgery
2006
Inflammatory Bowel Disease and Smoking
2004
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Pouchitis: What Every Gastroenterologist Needs to Know
2013
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
2004
European consensus on the histopathology of inflammatory bowel disease
2013
Ulcerative colitis
2012 Standout
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis
1999
Mast cell tryptases and chymases in inflammation and host defense
2007
In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis
1998
Ileal Pouch Anal Anastomosis
2013
Systematic review: infliximab therapy in ulcerative colitis
2006
Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials
2006
The development of allergic inflammation
2008 StandoutNature
Crohn's disease
2016 Standout
Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
2013
American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006
2007
Mast Cell Proteases
2007
Predictive and Protective Factors Associated With Colorectal Cancer in Ulcerative Colitis: A Case-Control Study
2006
Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis
2006
Treatment of distal ulcerative colitis with short-chain fatty acid enemas a placebo-controlled trial
1996
Immunity, Inflammation, and Cancer
2010 Standout
Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease
2005
Safety assessment of probiotics for human use
2010
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
2009
Clinical guidelines for the management of pouchitis
2009
Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis
2004
Acute Gastroenteritis Is Followed by an Increased Risk of Inflammatory Bowel Disease
2006
Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis
2006
Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens
2013
Probiotics and functional foods in gastrointestinal disorders
2002
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Is Perianal Crohn's Disease Associated with Intestinal Fistulization?
2005
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease
2007
New genes in inflammatory bowel disease: lessons for complex diseases?
2006
A Prospective Multivariate Analysis of Clinical Factors Associated With Pouchitis After Ileal Pouch–Anal Anastomosis
2007
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease
2006
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
2004 Standout
Ulcerative colitis
2016 Standout
Colonic Health: Fermentation and Short Chain Fatty Acids
2006 Standout
Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis
2003
Effects of dietary fiber on inflammatory bowel disease
2005
Health benefits of dietary fiber
2009 Standout
Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease
2013
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics
2004
Comparative effectiveness of azathioprine in Crohn’s disease and ulcerative colitis: prospective, long‐term, follow‐up study of 394 patients
2008
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
2004
Pouchitis and Pouch Dysfunction
2009
Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission
2010
Predictors of Pouchitis after Ileal Pouch-Anal Anastomosis: A Retrospective Review
2008
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease
2003
MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE
1999
Targeted Deletion of Metalloproteinase 9 Attenuates Experimental Colitis in Mice: Central Role of Epithelial-Derived MMP
2005
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia
2015
Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
2008
A Population-Based Case Control Study of Potential Risk Factors for IBD
2006
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
2003
Review article: altering the natural history of Crohn's disease – evidence for and against current therapies
2006
Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis
2000
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis
2002
A Genome Scan in 260 Inflammatory Bowel Disease-Affected Relative Pairs
2003
Family history of Crohnʼs disease is associated with an increased risk for Crohnʼs disease of the pouch
2008
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
2007
Systematic review: the management of pouchitis
2006
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Diagnostic difficulties in inflammatory bowel disease pathology
2005
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
Dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects
2007
Cancer-related inflammation
2008 StandoutNature
ACG Clinical Guideline: Management of Benign Anorectal Disorders
2014
Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine
2001
A Genome Scan in 260 Inflammatory Bowel Disease-Affected Relative Pairs
2004
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era
2009
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause?
2007
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Cancer surveillance in inflammatory bowel disease
1999
Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
2006
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies
2005
Radical causes of cancer
2003
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Guidelines for the management of inflammatory bowel disease in adults
2004
Association of 6-Thioguanine Nucleotide Levels and Inflammatory Bowel Disease Activity: A Meta-Analysis
2006
Endoscopic evaluation of patients with inflammatory bowel disease
2008
Evaluation of The Usefulness of Testing for P53 Mutations in Colorectal Cancer Surveillance for Ulcerative Colitis
1999
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells
2011
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
1997
Irritable Bowel Syndrome
2015 Standout
Ileal pouch–anal anastomosis
2007
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease
2016
Physiological and Anti‐Inflammatory Roles of Dietary Fiber and Butyrate in Intestinal Functions
1999
The Dietary Combination of Germinated Barley Foodstuff plus Clostridium butyricum Suppresses the Dextran Sulfate Sodium-induced Experimental Colitis in Rats
2000
Clinical Practice Guideline for the Surgical Management of Crohn’s Disease
2015
Colorectal cancer prevention in ulcerative colitis: a case‐control study
2000
Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis
1999
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
2014 Standout
Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.
1996
Review article: optimal preparation for surgery in Crohn's disease
2014
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, and nuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats
2006
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease
2006
Generation and Detection of Reactive Oxygen Species in Photocatalysis
2017 Standout
Review article: short chain fatty acids in health and disease
1998
Randomized Clinical Trial of Plantago Ovata Seeds (Dietary Fiber) As Compared With Mesalamine in Maintaining Remission in Ulcerative Colitis
1999
Clinical Implications of Inflammatory Bowel Disease Genetics on Phenotype
2005
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
Protease-Activated Receptors: Contribution to Physiology and Disease
2004
Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis
2004
A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch–anal anastomosis
2003
Physiology of Microglia
2011 Standout
Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-α)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells
1999
Works of Aaron Brzezinski being referenced
A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis
2001
The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis
1997
Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis
2011
Application of Wireless Capsule Endoscopy for the Evaluation of Iron Deficiency Anemia in Patients With Ileal Pouches
2008
Combined Ciprofloxacin and Tinidazole Therapy in the Treatment of Chronic Refractory Pouchitis
2007
Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients
2008
An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: A randomized, controlled trial
2005
Predictors of response to infliximab in patients with Crohn's disease
2002
Manometric Evaluation of Evacuatory Difficulty (Dyschezia) in Ileal Pouch Patients
2013
Differentiating risk factors for acute and chronic pouchitis
2005
Azathioprine Therapy in Chronic Ulcerative Colitis
1990
Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis
2002
Defining Complex Contributions of NOD2/CARD15 Gene Mutations, Age at Onset, and Tobacco Use On Crohn's Disease Phenotypes
2003
Association Between Immune-Associated Disorders and Adverse Outcomes of Ileal Pouch-Anal Anastomosis
2009
A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis
2003
Endoscopic Balloon Dilation of Ileal Pouch Strictures
2004
Celiac Disease Is Highly Prevalent in Lymphocytic Colitis
2001
Comprehensive Evaluation of Inflammatory and Noninflammatory Sequelae of Ileal Pouch-Anal Anastomoses
2005
Treatment of Rectal Cuff Inflammation (Cuffitis) in Patients with Ulcerative Colitis Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis
2004
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open‐label pilot study
2002
Risk Factors for Clinical Phenotypes of Crohn's Disease of the Ileal Pouch
2006
The Risk for Cancer Or Dysplasia in Ulcerative Colitis Patients With Primary Sclerosing Cholangitis
1999
Maintenance therapy with a probiotic in antibiotic‐dependent pouchitis: experience in clinical practice
2005
Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis
2001
Risk factors for pouch failure in patients with different phenotypes of Crohnʼs disease of the pouch
2008
Effect of Withdrawal of Nonsteroidal Anti-Inflammatory Drug Use on Ileal Pouch Disorders
2007
Indicators of Clinical Response to Treatment with Six-Mercaptopurine or Azathioprine in Patients with Inflammatory Bowel Disease
2004
Modified Pouchitis Disease Activity Index
2003
Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial
1996
Type of Fistula Determines Response to Infliximab in Patients with Fistulous Crohn's Disease
2004
Risk Factors for Diseases of Ileal Pouch–Anal Anastomosis After Restorative Proctocolectomy for Ulcerative Colitis
2006
Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.
1994
Clinical epidemiology of inflammatory bowel disease
1994
Treatment of left-sided ulcerative colitis with butyrate enemas: A randomized controlled trial
1995
Infliximab is more efficacious for treatment of enterocutaneous fistulas compared to rectovaginal fistulas in patients with Crohn's disease
2001
Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis.
1995